CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
19,20Â US$
arrow_downward
-0,10%(-0,020) 1K
14-okt, 15:35:18 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCHGCY tikeri uchun statistika yaratilmoqda...
Ochish
18,56Â US$
Yuqori
19,23Â US$
Past
18,33Â US$
Bozor kapitali
10,14Â trln
Oʻrtacha hajm
318,06Â ming
Hajmi
268,58Â ming
52 haftalik eng yuqori
34,84Â US$
52 haftalik eng past
18,33Â US$
Beta
0,56
Muomaladagi aksiyalar
3,36Â mlrd
Xodimlar soni
5Â ming
Ochish
18,56Â US$
Yuqori
19,23Â US$
Past
18,33Â US$
Bozor kapitali
10,14Â trln
Oʻrtacha hajm
318,06Â ming
Hajmi
268,58Â ming
52 haftalik eng yuqori
34,84Â US$
52 haftalik eng past
18,33Â US$
Beta
0,56
Muomaladagi aksiyalar
3,36Â mlrd
Xodimlar soni
5Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
10 soat oldin
Chugai reports vamikibart data for Chugai Pharmaceutical stock
Profil
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Chugai Pharmaceutical ADR haqida
CEOOsamu Okuda
Xodimlar soni5,1Â ming
Asos solingan10-mar, 1925
Bosh ofislar-
Sektor-
Veb-saytchugai-pharm.co.jp